Hemodynamic factors and perfusion abnormalities in early neurological deterioration

Stroke

Volumn 40, Issue 6, 2009, Pages

  Alawneh, Josef A ^a   Moustafa, Ramez Reda ^a   Baron, Jean Claude ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Disease progression; Imaging; Oligemia; Penumbra; Perfusion; Stroke

Indexed keywords

BLOOD PRESSURE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN PERFUSION; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DIFFUSION WEIGHTED IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; EXCITOTOXICITY; HUMAN; HYPERGLYCEMIA; HYPERTHERMIA; HYPOTHESIS; INFLAMMATION; NEUROIMAGING; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; BRAIN CIRCULATION; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR DISEASE; DISEASE COURSE; HEMODYNAMICS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DISEASE PROGRESSION; HEMODYNAMICS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; PROGNOSIS; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66849093890     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.532465     Document Type: Review

References (74)

1. 1. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000;31:2049-2054.
2. Yamamoto H, Bogousslavsky J, van Melle G. Different predictors of neurological worsening in different causes of stroke. Arch Neurol. 1998; 55:481-486.
3. Arenillas JF, Rovira A, Molina CA, Grive E, Montaner J, Alvarez-Sabin J. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ische- mic stroke. Stroke 2002;33:2197-2203.
4. Britton M, Roden A. Progression of stroke after arrival at hospital. Stroke 1985;16:629-632.
5. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344:156 -159.
6. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C. Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol. 1995;52:670-675.
7. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999;30:2631-2636.
8. Toni D, Fiorelli M, Zanette EM, Sacchetti ML, Salerno A, Argentino C, Solaro M, Fieschi C. Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultra-sonography. Stroke 1998;29:1144-1148.
9. Davalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40:1865-1869.
10. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis. 2004;17:242-252.
11. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, Calleja S, Garami Z, Khan K, Akhtar N, O'Rourke F, Shuaib A, Demchuk AM, Alexandrov AV. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007;38:69-74.
12. Ois A, Martinez-Rodriguez JE, Munteis E, Gomis M, Rodriguez-Campello A, Jimenez-Conde J, Cuadrado-Godia E, Roquer J. Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis. 2008;25:151-156.
13. Serena J, Rodriguez-Yanez M, Castellanos M. Deterioration in acute ischemic stroke as the target for neuroprotection. Cerebrovasc Dis. 2006; 21(suppl 2):80-88.
14. Castillo J, Leira R. Predictors of deteriorating cerebral infarct: role of inflammatory mechanisms. Would its early treatment be useful? Cere-brovasc Dis. 2001;11(suppl 1):40-48.
15. Toni D. Predictors of stroke deterioration. Cerebrovasc Dis. 1997;7(suppl 5):10-13.
16. Castillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis. 1999;9(suppl 3):1-8.
17. Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry. 2008;79:1093-1099.
18. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005;62:393-397.
19. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309-315.
20. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215-222.
21. Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, Chalela JA, Abbur R, McGrade H, Christou I, Krieger DW. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001;32:2117-2123.
22. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999;30:287-292.
23. von Kummer R, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994;15:9-15; discussion 16-18.
24. Lee SJ, Lee KH, Na DG, Byun HS, Kim YB, Shon YM, Cho SJ, Lee J, Chung CS, Hong SC. Multiphasic helical computed tomography predicts subsequent development of severe brain edema in acute ischemic stroke. Arch Neurol. 2004;61:505-509.
25. Manno EM, Nichols DA, Fulgham JR, Wijdicks EF. Computed tomo- graphic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc. 2003;78:156-160.
26. Haring HP, Dilitz E, Pallua A, Hessenberger G, Kampfl A, Pfausler B, Schmutzhard E. Attenuated corticomedullary contrast: an early cerebral computed tomography sign indicating malignant middle cerebral artery infarction. A case-control study. Stroke 1999;30:1076-1082.
27. Ryoo JW, Na DG, Kim SS, Lee KH, Lee SJ, Chung CS, Choi DS. Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr. 2004;28:55-62.
28. Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73:829-836.
29. Kucinski T, Koch C, Grzyska U, Freitag HJ, Kromer H, Zeumer H. The predictive value of early CT and angiography for fatal hemispheric swelling in acute stroke. AJNR Am J Neuroradiol. 1998;19:839-846.
30. Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998;29:2556-2562.
31. Oppenheim C, Samson Y, Manai R, Lalam T, Vandamme X, Crozier S, Srour A, Cornu P, Dormont D, Rancurel G, Marsault C. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000;31:2175-2181.
32. Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touze E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG. Sequential-design, multicenter, randomized, controlled trial of early DEcompressive Craniectomy In MALignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007;38:2506-2517.
33. Thomalla GJ, Kucinski T, Schoder V, Fiehler J, Knab R, Zeumer H, Weiller C, Rother J. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 2003;34:1892-1899.
34. Firlik AD, Yonas H, Kaufmann AM, Wechsler LR, Jungreis CA, Fukui MB, Williams RL. Relationship between cerebral blood flow and the development of swelling and life-threatening herniation in acute ischemic stroke. J Neurosurg. 1998;89:243-249.
35. Dohmen C, Bosche B, Graf R, Staub F, Kracht L, Sobesky J, Neveling M, Brinker G, Heiss WD. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003;34:2152-2158.
36. Schumann P, Touzani O, Young AR, Morello R, Baron JC, MacKenzie ET. Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure. Brain. 1998;121:1369 -1379.
37. Alvarez FJ, Segura T, Castellanos M, Leira R, Blanco M, Castillo J, Davalos A, Serena J. Cerebral hemodynamic reserve and early neurologic deterioration in acute ischemic stroke. J Cereb Blood Flow Metab. 2004; 24:1267-1271.
38. Zazulia AR, Videen TO, Powers WJ. Symptomatic autoregulatory failure in acute ischemic stroke. Neurology. 2007;68:389-390.
39. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35:520-526.
40. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet. 1997;349:79-83.
41. Davalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischemic stroke. Stroke 1997;28:708-710.
42. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.
43. Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute is-chemic stroke. Stroke 2003;34:671-675.
44. Davalos A, Castillo J, Pumar JM, Noya M. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis. 1997;7:64-69.
45. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28.
46. Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, Munuera J, Alvarez-Sabin J. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab. 2007;27:1616-1622.
47. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyper- glycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
48. Silva YS, et al. Abstracts of the 10th European Stroke Conference. Lisbon, Portugal, May 16-19, 2001. Cerebrovasc Dis. 2001;11(suppl 4): 1-134.
49. Rowat AM, Dennis MS, Wardlaw JM. Hypoxaemia in acute stroke is frequent and worsens outcome. Cerebrovasc Dis. 2006;21:166-172.
50. Singhal AB, Ratai E, Benner T, Vangel M, Lee V, Koroshetz WJ, Schaefer PW, Sorensen AG, Gonzalez RG. Magnetic resonance spec- troscopy study of oxygen therapy in ischemic stroke. Stroke 2007;38:2851-2854.
51. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, Buonanno FS, Gonzalez RG, Sorensen AG. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005;36:797-802.
52. Chiu EH, Liu CS, Tan TY, Chang KC. Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch Neurol. 2006;63:741-744.
53. Shin HK, Dunn AK, Jones PB, Boas DA, Lo EH, Moskowitz MA, Ayata C. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain. 2007;130:1631-1642.
54. Kim HY, Singhal AB, Lo EH. Normobaric hyperoxia extends the reper- fusion window in focal cerebral ischemia. Ann Neurol. 2005;57:571-575.
55. Takasawa M, Moustafa RR, Baron JC. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke. Stroke 2008;39:1629-1637.
56. Read SJ, Hirano T, Abbott DF, Markus R, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan GF, Scott AM, Bladin CF, McKay WJ, Donnan GA. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol. 2000;48:228-235.
57. Hillis AE, Wityk RJ, Barker PB, Ulatowski JA, Jacobs MA. Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 2003;34:2392-2396.
58. Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke. Lancet Neurol. 2006;5:755-768.
59. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol. 1999;46:568-578.
60. Thijs VN, Somford DM, Bammer R, Robberecht W, Moseley ME, Albers GW. Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging. Stroke 2004;35:94-98.
61. Muir KW, Halbert HM, Baird TA, McCormick M, Teasdale E. Visual evaluation of perfusion computed tomography in acute stroke accurately estimates infarct volume and tissue viability. J Neurol Neurosurg Psychiatry. 2006;77:334-339.
62. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, Pineda C, Serena J, van der Schaaf I, Waaijer A, Anderson J, Nesbit G, Gabriely I, Medina V, Quiles A, Pohlman S, Quist M, Schnyder P, Bogousslavsky J, Dillon WP, Pedraza S. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979-985.
63. Schaefer PW, Roccatagliata L, Ledezma C, Hoh B, Schwamm LH, Koroshetz W, Gonzalez RG, Lev MH. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy. AJNR Am J Neuroradiol. 2006;27:20-25.
64. Irino T, Watanabe M, Nishide M, Gotoh M, Tsuchiya T. Angiographical analysis of acute cerebral infarction followed by 'cascade'-like deterioration of minor neurological deficits. What is progressing stroke? Stroke 1983;14:363-368.
65. Johnston SC, Leira EC, Hansen MD, Adams HP Jr. Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol. 2003;54:439-444.
66. Grandin CB, Duprez TP, Smith AM, Mataigne F, Peeters A, Oppenheim C, Cosnard G. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke 2001;32:1147-1153.
67. Grandin CB. Assessment of brain perfusion with MRI: methodology and application to acute stroke. Neuroradiology. 2003;45:755-766.
68. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, Gillard JH, Williams GB, Aigbirhio FI, Warburton EA, Ostergaard L, Baron JC. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008;39:870-877.
69. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001;32:1581-1587.
70. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion-and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
71. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.
72. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Modder U, Freund HJ. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-1597.
73. Wittsack HJ, Ritzl A, Fink GR, Wenserski F, SieblerM, Seitz RJ, Modder U, Freund HJ. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology. 2002;222:397-403.
74. Sobesky J, Zaro Weber O, Lehnhardt FG, Hesselmann V, Thiel A, Dohmen C, Jacobs A, Neveling M, Heiss WD. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion- weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004;35:2843-2847.